These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1194 related articles for article (PubMed ID: 7794272)

  • 1. Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
    Hamby CV; Mendola CE; Potla L; Stafford G; Backer JM
    Biochem Biophys Res Commun; 1995 Jun; 211(2):579-85. PubMed ID: 7794272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a catalytically inactive H118Y mutant of nm23-H2 suppresses the metastatic potential of line IV Cl 1 human melanoma cells.
    Hamby CV; Abbi R; Prasad N; Stauffer C; Thomson J; Mendola CE; Sidorov V; Backer JM
    Int J Cancer; 2000 Nov; 88(4):547-53. PubMed ID: 11058869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of the tumor metastatic suppressor gene in mouse melanoma model: inverse association to metastatic potential.
    Meng L
    J Tongji Med Univ; 1998; 18(1):28-32, 36. PubMed ID: 10806798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A serine phosphorylation of Nm23, and not its nucleoside diphosphate kinase activity, correlates with suppression of tumor metastatic potential.
    MacDonald NJ; De la Rosa A; Benedict MA; Freije JM; Krutsch H; Steeg PS
    J Biol Chem; 1993 Dec; 268(34):25780-9. PubMed ID: 8245015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A low NM23.H1 gene expression identifying high malignancy human melanomas.
    Caligo MA; Grammatico P; Cipollini G; Varesco L; Del Porto G; Bevilacqua G
    Melanoma Res; 1994 Jun; 4(3):179-84. PubMed ID: 7919963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression.
    Mandai M; Konishi I; Koshiyama M; Mori T; Arao S; Tashiro H; Okamura H; Nomura H; Hiai H; Fukumoto M
    Cancer Res; 1994 Apr; 54(7):1825-30. PubMed ID: 7907945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High levels of Nm23 gene expression in advanced stage of thyroid carcinomas.
    Zou M; Shi Y; al-Sedairy S; Farid NR
    Br J Cancer; 1993 Aug; 68(2):385-8. PubMed ID: 8394105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominance of the metastatic phenotype in hybrids formed by fusion of mouse and human melanoma clones.
    van Golen KL; Risin S; Staroselsky A; Berger D; Tainsky MA; Pathak S; Price JE
    Clin Exp Metastasis; 1996 Mar; 14(2):95-106. PubMed ID: 8605733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A nucleoside diphosphate kinase A (nm23-H1) serine 120-->glycine substitution in advanced stage neuroblastoma affects enzyme stability and alters protein-protein interaction.
    Chang CL; Strahler JR; Thoraval DH; Qian MG; Hinderer R; Hanash SM
    Oncogene; 1996 Feb; 12(3):659-67. PubMed ID: 8637723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between NM23-H1 gene expression and metastasis of human uveal melanoma in an animal model.
    Ma D; Luyten GP; Luider TM; Jager MJ; Niederkorn JY
    Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2293-301. PubMed ID: 8843913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localization of a second NM23 gene, NME2, to chromosome 17q21-q22.
    Kelsell DP; Black DM; Solomon E; Spurr NK
    Genomics; 1993 Aug; 17(2):522-4. PubMed ID: 8406509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the nm23-2/NDP kinase alpha gene in rat mammary and oral carcinoma cells of varying metastatic potential.
    Henderson BR
    Br J Cancer; 1993 Nov; 68(5):874-8. PubMed ID: 8217603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of the nm23 metastasis-suppressor gene product in skin tumors.
    Kanitakis J; Euvrard S; Bourchany D; Faure M; Claudy A
    J Cutan Pathol; 1997 Mar; 24(3):151-6. PubMed ID: 9085150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced tumor incidence, metastatic potential, and cytokine responsiveness of nm23-transfected melanoma cells.
    Leone A; Flatow U; King CR; Sandeen MA; Margulies IM; Liotta LA; Steeg PS
    Cell; 1991 Apr; 65(1):25-35. PubMed ID: 2013093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mRNA levels of nm23 in murine ascites hepatoma (H22) clones with different lymphatic metastatic potential.
    Jiang XP; Tang ZY; Liu KD; Zhou XD; Lin ZY; Ling MY; Wu XF
    J Cancer Res Clin Oncol; 1996; 122(1):55-8. PubMed ID: 8543593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential nm23 gene expression at the fetal-maternal interface.
    Shi Y; Parhar RS; Zou M; al-Sedairy S; Farid NR
    Br J Cancer; 1994 Sep; 70(3):440-4. PubMed ID: 8080727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of nm23-H2/NDP kinase B in a human oral squamous cell carcinoma cell line results in reduced metastasis, differentiated phenotype in the metastatic site, and growth factor-independent proliferative activity in culture.
    Miyazaki H; Fukuda M; Ishijima Y; Takagi Y; Iimura T; Negishi A; Hirayama R; Ishikawa N; Amagasa T; Kimura N
    Clin Cancer Res; 1999 Dec; 5(12):4301-7. PubMed ID: 10632374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Site-directed mutagenesis of nm23-H1. Mutation of proline 96 or serine 120 abrogates its motility inhibitory activity upon transfection into human breast carcinoma cells.
    MacDonald NJ; Freije JM; Stracke ML; Manrow RE; Steeg PS
    J Biol Chem; 1996 Oct; 271(41):25107-16. PubMed ID: 8810265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NM23 in human melanoma progression and metastasis.
    Easty DJ; Maung K; Lascu I; Véron M; Fallowfield ME; Hart IR; Bennett DC
    Br J Cancer; 1996 Jul; 74(1):109-14. PubMed ID: 8679442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressive role of the metastasis-related nm23-H1 gene in human ovarian carcinomas: association of high messenger RNA expression with lack of lymph node metastasis.
    Viel A; Dall'Agnese L; Canzonieri V; Sopracordevole F; Capozzi E; Carbone A; Visentin MC; Boiocchi M
    Cancer Res; 1995 Jun; 55(12):2645-50. PubMed ID: 7780979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.